Latest Breaking News On - Corporate executive committee - Page 6 : comparemela.com

F Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023

Christoph Franz has decided not to seek re-election to the Board of Directors at the Annual General Meeting (AGM) in March 2023 The Board of Directors intends to propose Severin Schwan as new Chairman

United statesSeverin schwanThomas schineckerChristoph franzNathalie altermattRoche groupDiagnostics divisionRoche group media relationsCorporate executive committeeAnnual general meetingAnnual generalRoche boardMolecular biologyCorporate executiveDow jones sustainability indicesChugai pharmaceutical

[Ad hoc announcement pursuant to Art 53 LR] Roche: Change

Christoph Franz has decided not to seek re-election to the Board of Directors at the Annual General Meeting (AGM) in March 2023 The Board of Directors.

United statesSeverin schwanThomas schineckerChristoph franzNathalie altermattRoche groupDiagnostics divisionRoche group media relationsCorporate executive committeeAnnual general meetingAnnual generalRoche boardMolecular biologyCorporate executiveDow jones sustainability indicesChugai pharmaceutical

Boston Pharmaceuticals Appoints Dr Sophie Kornowski as Chair of its Board of Directors and Acting Chief Executive

Boston Pharmaceuticals Appoints Dr Sophie Kornowski as Chair of its Board of Directors and Acting Chief Executive
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGurnet pointSophie kornowskiErnesto bertarelliJoannet beckTom johnson owain thorogoodStefan meisterCraigt bassonParis descartes universityUniversity of chicago boothBoston pharmaceuticalsChugai pharmaceuticalsCorporate developmentCorporate executive committeeResearch institutions

Boston Pharmaceuticals Appoints Dr Sophie Kornowski as Chair of its Board of Directors and Acting C

CAMBRIDGE, Mass. (BUSINESS WIRE) Boston Pharmaceuticals, a clinical stage biopharmaceutical company, today announced the appointment of Dr. Sophie Kornowski as Chair of its Board of Directors and Acting Chief Executive Officer, effective immediately. Dr. Kornowski succeeds interim Co-CEOs Dr. Joanne T. Beck and Dr.

United statesUnited kingdomGurnet pointSophie kornowskiErnesto bertarelliJoannet beckTom johnson owain thorogoodStefan meisterCraigt bassonParis descartes universityUniversity of chicago boothBoston pharmaceuticalsChugai pharmaceuticalsCorporate developmentCorporate executive committeeResearch institutions

Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors

29.04.2022 Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors | Baloise Holding AG | News | Nachricht | Mitteilung

United statesMaya bundtAndreas beerliThomas pleinesBaloise holding ag keyZurich insurance groupSwiss exchangeHolding ltdRemuneration committeeAudit committeeBaloise groupCyber digital solutions departmentCorporate executive committeeBaloise holdingGeneral meetingAnnual general meeting